| 25A519 |
Bristol Myers Squibb Company v. Robert F. Kennedy, Secretary of Health and Human Services, et al. |
Third Circuit |
2025-11-05 |
Application |
|
constitutional-challenge drug-pricing fifth-amendment first-amendment inflation-reduction-act medicare-drug-negotiation |
Whether the Medicare Drug Price Negotiation Program created by the Inflation Reduction Act of 2022 violates the Fifth and First Amendments |
| 25-348 |
AstraZeneca Pharmaceuticals LP, et al. v. Robert F. Kennedy, Secretary of Health and Human Services, et al. |
Third Circuit |
2025-09-24 |
Pending |
|
drug-price-negotiation due-process government-pricing inflation-reduction-act medicare-transactions pharmaceutical-manufacturers |
Whether the IRA implicates an interest of pharmaceutical manufacturers that is protected by the Due Process Clause. |
| 25A115 |
AstraZeneca Pharmaceuticals LP, et al. v. Robert F. Kennedy, Secretary of Health and Human Services, et al. |
Third Circuit |
2025-07-28 |
Presumed Complete |
|
drug-price-negotiation due-process inflation-reduction-act medicare patent-rights pharmaceutical-regulation |
Whether the government's mandatory drug price negotiation program under the Inflation Reduction Act violates pharmaceutical manufacturers' due process… |